1. Japan Society of Clinical Oncology provisional clinical opinion for the diagnosis and use of immunotherapy in patients with deficient DNA mismatch repair tumors, cooperated by Japanese Society of Medical Oncology, First Edition

   • Saori Mishima
   • Hiroya Taniguchi
   • Takayuki Yoshino

   Special Article Open access 08 July 2019 Pages: 217 - 239

   

2. Corticosteroid switch after progression on abiraterone acetate plus prednisone

   • Giandomenico Roviello
   • Navid Sobhani
   • Alberto D’Angelo

   Review Article 08 November 2019 Pages: 240 - 246

   

3. Prognostic value of alkaline phosphatase in hormone-sensitive prostate cancer: a systematic review and meta-analysis

   • Keiichiro Mori
   • Florian Janisch
   • Shahrokh F. Shariat

   Review Article Open access 25 November 2019 Pages: 247 - 257

   

4. Pretreatment predictive factors for feasibility of oral intake in adjuvant concurrent chemoradiotherapy for patients with locally advanced squamous cell carcinoma of the head and neck

   • Hidenori Kimura
   • Satoshi Hamauchi
   • Tomoya Yokota

   Original Article 16 October 2019 Pages: 258 - 266

   

5. Retrospective study on bevacizumab in the treatment of non-small cell lung cancer with brain metastases

   • Zhen Wang
   • Jin-Ji Yang
   • Yi-Long Wu

   Original Article 05 October 2019 Pages: 267 - 273

   

6. Impact of histology on patterns of failure and clinical outcomes in patients treated with definitive chemoradiotherapy for locally advanced non-small cell lung cancer

   • Hitoshi Ito
   • Yukinori Matsuo
   • Takashi Mizowaki

   Original Article 30 October 2019 Pages: 274 - 281

   

7. The utility of ground-glass attenuation score for anticancer treatment-related acute exacerbation of interstitial lung disease among lung cancer patients with interstitial lung disease

   • Naoki Nishiyama
   • Takayuki Honda
   • Yasunari Miyazaki

   Original Article 13 November 2019 Pages: 282 - 291

   

8. Clinicopathologic characteristics of malignant non-hematopoietic tumors first presented as an axillary mass with emphasis on occult breast carcinoma

   • Thaer Khoury
   • Ana Lucia Ruano Mendez
   • Emilian Racila

   Original Article 04 October 2019 Pages: 292 - 300

   

9. Pertuzumab plus trastuzumab and chemotherapy for Japanese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subgroup analysis of the JACOB trial

   • Kohei Shitara
   • Hiroki Hara
   • Kei Muro

   Original Article Open access 16 October 2019 Pages: 301 - 311

   

10. Association of MTHFR gene polymorphisms with pancreatic cancer: meta-analysis of 17 case–control studies

    • Fangfang Nie
    • Mingli Yu
    • Wanyang Liu

    Original Article 07 November 2019 Pages: 312 - 321

    

11. FDG-PET reflects tumor viability on SUV in colorectal cancer liver metastasis

    • Akira Watanabe
    • Norifumi Harimoto
    • Ken Shirabe

    Original Article 14 October 2019 Pages: 322 - 329

    

12. Factors affecting R0 resection of colorectal cancer with synchronous peritoneal metastases: a multicenter prospective observational study by the Japanese Society for Cancer of the Colon and Rectum

    • Dai Shida
    • Hirotoshi Kobayashi
    • Kenichi Sugihara

    Original Article 01 November 2019 Pages: 330 - 337

    

13. Expression of PBRM1 as a prognostic predictor in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitor

    • Wen Cai
    • Zaoyu Wang
    • Wei Xue

    Original Article 13 November 2019 Pages: 338 - 346

    

14. ‘Trifecta’ outcomes of robot-assisted partial nephrectomy: a large Japanese multicenter study

    • Junya Furukawa
    • Hiroomi Kanayama
    • Masato Fujisawa

    Original Article 01 November 2019 Pages: 347 - 353

15. A single-institute experience of trimodal bladder-preserving therapy for histologic variants of urothelial carcinoma

    • Yoshiyuki Nagumo
    • Takahiro Kojima
    • Hiroyuki Nishiyama

    Original Article 08 October 2019 Pages: 354 - 361

    

16. Influence of pretreatment quality of life on prognosis in patients with urothelial carcinoma

    • Sappaya Suppanuntaroek
    • Shingo Hatakeyama
    • Chikara Ohyama

    Original Article 26 October 2019 Pages: 362 - 369

    

17. Pre-treatment ratio of periprostatic to subcutaneous fat thickness on MRI is an independent survival predictor in hormone-naïve men with advanced prostate cancer

    • Takeshi Sasaki
    • Yusuke Sugino
    • Hideki Kanda

    Original Article 15 October 2019 Pages: 370 - 376

    

18. The significance of micro-lymphatic invasion and pathological Gleason score in prostate cancer patients with pathologically organ-confined disease and negative surgical margins after robot-assisted radical prostatectomy

    • Takeshi Hashimoto
    • Jun Nakashima
    • Yoshio Ohno

    Original Article 31 October 2019 Pages: 377 - 383

    

19. The role of additional hysterectomy after concurrent chemoradiation for patients with locally advanced cervical cancer

    • Kosuke Yoshida
    • Hiroaki Kajiyama
    • Fumitaka Kikkawa

    Original Article 24 September 2019 Pages: 384 - 390

    

20. Leptomeningeal metastases arising from gynecological cancers

    • Hiroko Yano
    • Shoji Nagao
    • Satoshi Yamaguchi

    Original Article 04 October 2019 Pages: 391 - 395

    

21. The efficacy and safety of the addition of olanzapine to ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy

    • Veerisa Vimolchalao
    • Siwat Sakdejayont
    • Suebpong Tanasanvimon

    Original Article 27 November 2019 Pages: 396 - 402